Ray:
Have you read the peer-reviewed paper released by NTRP, which explains the subgroup analysis?
Specifically how the non-Memantine 20ug group improved in SIB and was statistically significant vs placebo?
Or maybe the science doesn't matter to you? Perhaps you think it's just another Alzheimer's trial, and because most other Alzheimer's trials fail, this one will too?
--------------
If the results released in Aug/Sep are statistically significant, the stock will be multiples of where we are today.